We are live on ! Find out more
AIP

ARS Investment Partners Portfolio holdings

AUM $2.29B
1-Year Est. Return 113.95%
This Fund
S&P 500
This Quarter Est. Return
+7.53%
1 Year Est. Return
+113.95%
3 Year Est. Return
+260.1%
5 Year Est. Return
+332.48%
10 Year Est. Return
+1,634.5%
AUM
$827M
AUM Growth
+$50.8M
Cap. Flow
+$6.63M
Cap. Flow %
0.8%
Top 10 Hldgs %
31.68%
Holding
163
New
11
Increased
50
Reduced
65
Closed
8

Top Buys

Rank Stock Value
1
IBM icon
IBM
IBM
+$15.7M
2
BIIB icon
Biogen
BIIB
+$5.11M
3
EBIX
Ebix Inc
EBIX
+$4.16M
4
K
Kellanova
K
+$3.77M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$3.46M

Top Sells

Rank Stock Value
1
NUE icon
Nucor
NUE
+$11.8M
2
COST icon
Costco
COST
+$6.67M
3
WDC icon
Western Digital
WDC
+$5.54M
4
AAPL icon
Apple
AAPL
+$4.49M
5
TWX
Time Warner Inc
TWX
+$3.89M

Sector Composition

Rank Sector Weight
1 Technology 30.1%
2 Industrials 12.59%
3 Communication Services 10.51%
4 Healthcare 10.04%
5 Consumer Discretionary 6.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MARK
126
DELISTED
Remark Holdings, Inc.
MARK
$687K 0.08%
+7,060
New +$417K
ICF icon
127
iShares Select U.S. REIT ETF
ICF
$2.1B
$666K 0.08%
13,150
CNTY icon
128
Century Casinos
CNTY
$33.2M
$663K 0.08%
72,648
-30,000
-29% -$261K
PAF
129
DELISTED
Invesco FTSE RAFI Asia Pacific ex-Japan ETF
PAF
$639K 0.08%
10,850
HD icon
130
Home Depot
HD
$332B
$633K 0.08%
3,339
TMO icon
131
Thermo Fisher Scientific
TMO
$214B
$629K 0.08%
3,311
-27
-0.8% -$5.17K
HII icon
132
Huntington Ingalls Industries
HII
$12.6B
$625K 0.08%
2,650
IWV icon
133
iShares Russell 3000 ETF
IWV
$19.5B
$543K 0.07%
3,435
XOM icon
134
ExxonMobil
XOM
$651B
$498K 0.06%
5,949
+40
+0.7% +$3.31K
XLU icon
135
State Street Utilities Select Sector SPDR ETF
XLU
$23B
$448K 0.05%
17,018
+390
+2% +$10.7K
GILD icon
136
Gilead Sciences
GILD
$163B
$401K 0.05%
5,600
-10
-0.2% -$759
HTGC icon
137
Hercules Capital
HTGC
$2.98B
$394K 0.05%
+30,000
New +$392K
REM icon
138
iShares Mortgage Real Estate ETF
REM
$545M
$376K 0.05%
8,315
NBIX icon
139
Neurocrine Biosciences
NBIX
$18.7B
$349K 0.04%
4,500
CSCO icon
140
Cisco
CSCO
$448B
$347K 0.04%
+9,053
New +$323K
STL
141
DELISTED
Sterling Bancorp
STL
$298K 0.04%
12,112
-97
-0.8% -$2.4K
PX
142
DELISTED
Praxair Inc
PX
$294K 0.04%
1,900
MDP
143
DELISTED
Meredith Corporation
MDP
$281K 0.03%
+4,250
New +$256K
V icon
144
Visa
V
$684B
$263K 0.03%
2,307
DEO icon
145
Diageo
DEO
$49.5B
$250K 0.03%
1,713
-75
-4% -$10.3K
PG icon
146
Procter & Gamble
PG
$335B
$246K 0.03%
2,672
-443
-14% -$39.8K
SBUX icon
147
Starbucks
SBUX
$121B
$246K 0.03%
4,286
-467
-10% -$26.4K
LLY icon
148
Eli Lilly
LLY
$1.03T
$245K 0.03%
2,900
PPLT
149
abrdn Physical Platinum Shares ETF
PPLT
$1.89B
$221K 0.03%
25,000
MA icon
150
Mastercard
MA
$510B
$200K 0.02%
+1,324
New +$197K

Similar funds

ARS Investment Partners's Q4 2017 Portfolio in Review

As of Q4 2017, ARS Investment Partners held 163 positions worth $827M, up 6.5% from $776M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

ARS Investment Partners's Q4 2017 filing shows 11 new, 50 increased, 65 reduced and 8 closed positions. Its largest new stake was Ebix Inc: 57,229 shares worth $4.54M. The largest sale was Nucor, an estimated $11.8M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Industrials and Communication Services.

  • ARS Investment Partners's largest Q4 2017 buy was Ebix Inc: 57,229 shares worth $4.54M.
  • ARS Investment Partners added most to IBM in Q4 2017, an estimated $15.7M increase.
  • ARS Investment Partners's biggest Q4 2017 reduction was Western Digital, cutting an estimated $5.54M.
  • ARS Investment Partners fully exited Nucor in Q4 2017, selling an estimated $11.8M.
  • ARS Investment Partners's ten largest holdings make up 32% of its $827M portfolio in Q4 2017.
  • ARS Investment Partners opened 11 new positions and closed 8 in Q4 2017.
  • ARS Investment Partners's portfolio value rose 6.5% quarter-over-quarter to $827M.

Based on ARS Investment Partners's 13F filing for Q4 2017, filed 14 Feb 2018.